Krishnendu Roy, Ph. D.

Key considerations in Large Scale, Low-Cost Manufacturing of High Quality Therapeutic Cells: A perspective from the National Cell Manufacturing Consortium

  • Krishnendu RoyFellow, AIMBE
  • Fellow, BMES
  • Technical Lead, National Cell Manufacturing Consortium
  • Robert A. Milton Chair
  • Director, Marcus Center for Cell-Therapy Characterization and Manufacturing (MC3M)
  • Director, Center for ImmunoEngineering at Georgia Tech
  • The Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University
  • The Parker H. Petit Institute for Bioscience and Bioengineering

Dr. Krishnendu (Krish) Roy received his undergraduate degree from the Indian Institute of Technology (India) followed by his MS from Boston University and his PhD in Biomedical Engineering from Johns Hopkins University. Following his PhD, he joined Zycos Inc., a start-up biotechnology company where he served first as a Scientist and then as a Senior Scientist in the Drug Delivery Research group.  Dr. Roy left his industrial position to join The University of Texas at Austin in 2002, where he was most recently Professor and Fellow of the Cockrell Chair in Engineering Excellence.  He left UT-Austin in July of 2013 to move to Georgia Tech. where he is currently the Robert A. Milton Chair. At Georgia Tech, he also serves as the Director of the newly established Marcus Center for Cell-Therapy Characterization and Manufacturing as well as the Director of the Center for ImmunoEngineering, a consortium of 30+ faculty focused on using engineering tools and methodologies to understand and modulate the immune system in health and disease. He is also the Technical Lead of the NIST/AMTech National Cell Manufacturing Consortium (NCMC), a national public-private partnership, focused on addressing the challenges and solutions for large scale manufacturing of therapeutic cells.  Dr. Roy’s research interests are in the areas of scalable cell manufacturing, Immuno-engineering, stem-cell engineering and controlled drug and vaccine delivery technologies, with particular focus in biomedical materials. In recognition of his seminal contribution to these fields, Dr. Roy has been elected Fellow of the American Institute for Medical and Biological Engineering (AIMBE) and Fellow of the Biomedical Engineering Society (BMES). In addition, Dr. Roy has received numerous awards and honors including Young Investigator Awards from both the Controlled Release Society (CRS) and The Society for Biomaterials (SFB), the Young Scientist Award from HSEMB, NSF CAREER award, Global Indus Technovator Award from MIT, the CRS Cygnus Award etc. He is also the recipient of Best Teacher Award given by the Biomedical Engineering Students at The University of Texas and the best advisor award given by bioengineering students at Georgia Tech. He serves as a member of the Editorial Boards of the Journal of Controlled Release and the European Journal of Pharmaceutics and Biopharmaceutics. He also serves as a member of the Forum on Regenerative Medicine of the National Academies and as co-Chair of the Working Group of the Standards Coordinating Body (SCB) for Cell and Regenerative Therapies.